Health News Roundup: Ebola kills doctor in Uganda, first health worker killed in latest outbreak; Moderna refused China request to reveal vaccine technology - FT and more

The Cambridge, Massachusetts-based pharmaceutical company turned down China’s request to hand over the recipe for its mRNA vaccine because of commercial and safety concerns, the newspaper said, citing people involved in negotiations that took place between 2020 and 2021, adding that the vaccine maker is still “eager” to sell the product to China. Italy drops COVID-19 face mask rule for public transport Italians will no longer have to wear face masks on public transport, the health ministry said late on Thursday, in the latest easing of rules against the coronavirus pandemic.

Following is a summary of current health news briefs.

Ebola kills doctor in Uganda, first health worker killed in latest outbreak

A Tanzanian doctor working in Uganda who contracted Ebola has died, the first health worker killed by the disease in the latest outbreak in the country, Uganda's health minister said on Saturday. "I regret to announce that we have lost our first doctor, Dr. Mohammed Ali, a Tanzanian national, 37-year-old Male," the health minister, Jane Ruth Aceng, tweeted.

Moderna refused China request to reveal vaccine technology - FT

Moderna Inc has refused to hand over to China the core intellectual property behind the development of its COVID-19 vaccine, leading to a collapse in negotiations on its sale there, the Financial Times reported on Saturday, citing people familiar with the matter. The Cambridge, Massachusetts-based pharmaceutical company turned down China’s request to hand over the recipe for its mRNA vaccine because of commercial and safety concerns, the newspaper said, citing people involved in negotiations that took place between 2020 and 2021, adding that the vaccine maker is still “eager” to sell the product to China.

Italy drops COVID-19 face mask rule for public transport

Italians will no longer have to wear face masks on public transport, the health ministry said late on Thursday, in the latest easing of rules against the coronavirus pandemic. The ministry said a decree requiring mask wearing on trains, buses and ferries, expiring on Friday, would not be renewed. The obligation was extended, however, for hospitals and care homes.

Two thirds of U.S. adults don't plan on getting COVID boosters soon - poll

Around two-thirds of adults in the United States do not plan to get updated COVID-19 booster shots soon, according to a survey conducted by the Kaiser Family Foundation (KFF), a health policy nonprofit organization. Only a third of adults polled said they either already received the updated shots or plan to get the booster as soon as possible, the poll found.

A Chinese mRNA COVID vaccine is approved for the first time - in Indonesia

Indonesia said it has granted emergency use approval to an mRNA COVID-19 vaccine developed by a Chinese company, becoming the first country, ahead of even China, to do so. Indonesia's food and drugs agency (BPOM) greenlighted the use of Walvax Biotechnology Co Ltd's mRNA vaccine, which has been in development for more than two years and targets the original strain of the coronavirus.

Amylyx prices newly approved ALS drug at $158,000 per year

Amylyx Pharmaceuticals Inc on Friday set the list price of its newly approved drug to treat amyotrophic lateral sclerosis (ALS) at about $158,000 per year in the United States, a discount to its most recently approved competitor. The drug Relyvrio was approved by the U.S. Food and Drug Administration on Thursday, making it the third ALS treatment to get the regulator's nod after Japanese firm Mitsubishi Tanabe's Radicava, priced at around $170,000 per year, and the generic drug riluzole.

As Australia calls end to COVID emergency response, doctors warn of risk to public

Australia will end the mandatory five-day home quarantine for COVID-infected people on Oct. 14, Prime Minister Anthony Albanese said on Friday, even as some doctors warned the move would put the public at risk. The decision to let COVID-infected Australians decide whether they need to isolate or not removes one of the country's last remaining restrictions from the pandemic era, and comes about a month after the quarantine period was cut to five days from seven.

Analysis-Eisai's trial success raises hope for Alzheimer's prevention

Clear evidence this week that Eisai and Biogen's drug lecanemab slows cognitive decline in early-stage dementia has galvanized efforts among Alzheimer's researchers toward a tantalizing goal - preventing dementia even before symptoms start. Lecanemab is an antibody that targets and removes toxic clumps of a protein called amyloid beta that accumulates in the brains of patients with Alzheimer's. Results from the companies' 1,800-patient trial released on Tuesday showed convincingly that doing so also slows the advance of the mind-robbing disease.

Chinese artist records era of COVID, one test at a time

For most of China's 1.4 billion people, regular COVID-19 tests have become a way of life. Siyuan Zhuji is trying to turn them into a work of art. Since March, the 33-year-old multi-disciplinary artist from Jiangsu province has been filming his own nucleic acid tests with a small camera in his mouth.

Cholera outbreaks surging worldwide, fatality rates rising - WHO

Cholera cases have surged this year, especially in places of poverty and conflict, with outbreaks reported in 26 countries and fatality rates rising sharply, a World Health Organization official said on Friday. In a typical year, fewer than 20 countries report outbreaks of the disease which is spread by the ingestion of contaminated food or water and can cause acute diarrhea.

(With inputs from agencies.)